Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Merck And Co Inc (MRK)

2014-04-17@14:19:39 ET
US Patent Issued to Merck Sharp & Dohme on April 15 for "Crystalline polymorphic forms of an antidiabetic compound" (Irish, American, British, Chinese Inventors) (ABW)

2014-04-17@13:06:33 ET
US Patent Issued to Merck Patent on April 15 for "Material for functional layer of organic electronic component" (German, Australian Inventors) (ABW)

2014-04-17@12:39:48 ET
Merck Serono's President & CEO Belen Garijo has Been Appointed to Board of Directors of L'Oreal (EUR)

2014-04-17@12:37:00 ET

2014-04-17@07:31:13 ET
Global Perennial Allergic Rhinitis Pipeline Review 2014 - Analysis of 10 Company Profiles & 12 Drug Profiles (MTO)

2014-04-17@05:34:27 ET
Global Malignant Mesothelioma Clinical Trials Review 2014 - Profiles of 10 Companies & 9 Organisations (MTO)

2014-04-17@00:40:01 ET
FDA Grants Approval to Merck's Grastek (Timothy Grass Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Grass Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Children and Adults (CLM)

2014-04-16@13:25:26 ET
Merck (MRK) Showing Resistance Near $57.02 (FBM)

2014-04-16@11:31:50 ET
Global Nasopharyngeal Cancer Clinical Trials Review 2014 - Featuring 19 Companies/Organisations (MTO)

2014-04-16@10:30:11 ET
Merck (MRK) Crosses Pivot Point Resistance at $56.54 (F79)

2014-04-16@07:54:00 ET
Physicians Interactive's Transformative Omnio Medical App Expands from iPad to iPhone, Android Versions (PRN)

2014-04-16@05:54:36 ET
World Market for Biosimilars to 2017: EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others (MTO)

2014-04-16@05:23:01 ET
Merck announces encouraging interim results from Phase II hepatitis C study (DTM)

2014-04-15@13:24:15 ET
Healthcare Stocks Declining Again; Halozyme Giving Back Early Gains Linked to Citigroup 'Buy' Rating (MID)

2014-04-15@13:16:39 ET
Sector Update: Healthcare (MID)

2014-04-15@09:49:36 ET
Merck (MRK) Showing Neutral Technicals With Resistance At $57.53 (FBM)

2014-04-15@08:53:30 ET
Sector Update: Healthcare Shares Higher Pre-Market; FDA Approves Merck's Grastek Tablet (MID)

2014-04-15@08:50:11 ET
Sector Update: Healthcares (MID)

2014-04-15@08:00:00 ET
Interim Clinical Study Results, Leadership Appointments, and Earnings Release Schedules - Analyst Notes on Merck, Magellan, ABIOMED, CONMED, and Greatbatch (PRN)

2014-04-15@04:57:20 ET
Form 144: Filing to Sell 145225 Shares of Merck & Co Inc (MRK) (VKR)